XRX
52
-3
C
60
-2
CVS
45
-4
EL
30
-3
MPC
52
8
ITW
62
-2
MMC
58
-2
COST
56
3
NTRS
49
-5
ADT
32
9
OMC
64
-2
TGT
50
-2
CNX
80
4
MAT
51
-3
NSC
62
-5
EFX
63
-6
QCOM
55
-4
IVZ
50
-3
EXC
53
6
FLR
52
4
XRX
52
-3
C
60
-2
CVS
45
-4
EL
30
-3
MPC
52
8
ITW
62
-2
MMC
58
-2
COST
56
3
NTRS
49
-5
ADT
32
9
OMC
64
-2
TGT
50
-2
CNX
80
4
MAT
51
-3
NSC
62
-5
EFX
63
-6
QCOM
55
-4
IVZ
50
-3
EXC
53
6
FLR
52
4
Financhill
Back

Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64

REGN
Regeneron Pharmaceuticals

Last Price:
1,144.34
Seasonality Move:
4.55%

7 Day Trial

ALL ACCESS PASS

$ 7

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Regeneron Pharmaceuticals Price Quote

$1,144.34
-0.56 (-0.51%)
(Updated: September 21, 2024 at 6:40 AM ET)

Regeneron Pharmaceuticals Key Stats

Buy
64
Regeneron Pharmaceuticals (REGN) is a Buy
Day range:
$1,136.22 - $1,149.42
52-week range:
$769.19 - $1,211.20
Dividend yield:
0%
P/E ratio:
32.93
P/S ratio:
9.71
P/B ratio:
4.47%
Volume:
479.6K
Avg. volume:
437.2K
1-year change:
37.67%
Market cap:
$126.2B
Revenue:
$13.1B
EPS:
$37.76

How Much Does Regeneron Pharmaceuticals Make?

Is Regeneron Pharmaceuticals Growing As A Company?

Regeneron Pharmaceuticals Stock Price Performance

What Is Regeneron Pharmaceuticals 52-Week High & Low?

Regeneron Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Regeneron Pharmaceuticals?

Is Regeneron Pharmaceuticals Cash Flow Positive?

  • What Is REGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.1B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.8B

Regeneron Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    REGN return on invested capital is 15.43%
  • What Is Regeneron Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 12.99%
  • What Is REGN Return On Equity?
    ROE is a measure of profitability and is 16.61%

Regeneron Pharmaceuticals Earnings Date & Stock Price

Regeneron Pharmaceuticals Competitors

Regeneron Pharmaceuticals Dividend Yield

Regeneron Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 46% 8.83%
Revenue: 12.32% 4.51%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 1,162.19
Upside from Last Price: 1.51%

Major Shareholders

  • How many REGN shares are owned by institutional investors?
    171.7M REGN shares are owned by institutional investors
  • How many REGN shares are owned by insiders?
    2.1M REGN shares are owned by insiders